Search results
Results from the WOW.Com Content Network
Genentech, Inc. is an American biotechnology corporation headquartered in South San Francisco, California, wholly owned by the Swiss multinational pharmaceutical company, the Roche Group. It became an independent subsidiary of Roche in 2009.
Kleiner and Perkins provided $100,000 on the May closing, and acquired 20,000 shares of preferred stock from Genentech. [6] Swanson was made the president and treasurer of Genentech, and received a $2,500 per month salary, along with 25,000 shares. [6] This marked the end of Swanson's unemployment, and the beginning of his career at Genentech ...
Genentech became a wholly owned subsidiary group of Roche on 25 March 2009. [27] Roche began vacating the NJ site in 2012, and sold it off in 2016. [28] Roche acquired Medingo Ltd. in April 2010, for $160 million [29] and BioImagene, Inc. in August for $100 million. [30]
Andrew Challenger, senior vice president of Challenger, Gray & Christmas Inc. in Chicago, said people don’t lose their jobs immediately when such announcements are made.
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
Genentech hired him in 2003 as its senior vice president of Research Drug Discovery. He cited the firm's "potential to create breakthrough therapies for unmet medical needs" as his reason for leaving academia. [3] [21] His research on the development of the brain has uncovered details of how Alzheimer's disease is triggered. [3]
The Fulton County Jail, including its south annex and two other locations, is part of a federal investigation the Justice Department announced last month that alleges inmates' civil rights are ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us; Pages for logged out editors learn more